Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 530.0 | 50 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 608.0 | 43 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | M-CSF | 655.5 | 42 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 914.5 | 56 | |
N2759 | TNF-a | 100 | ng/mL | 3 | M-CSF | 1173.0 | 45 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 721.5 | 60 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | M-CSF | 581.0 | 27 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 616.5 | 58 | |
N2586 | TNF-a | 100 | ng/mL | 3 | M-CSF | 529.5 | 62 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 446.0 | 43 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | M-CSF | 319.0 | 47 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 488.0 | 66 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | M-CSF | 520.0 | 61 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 448.0 | 47 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | M-CSF | 324.5 | 42 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 325.0 | 43 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | M-CSF | 327.0 | 39 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 348.0 | 35 | ||||
RA1869 | 3 | M-CSF | 388.0 | 62 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 525.0 | 43 | ||||
N2759 | 3 | M-CSF | 475.0 | 41 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 419.0 | 33 | ||||
RA1931 | 3 | M-CSF | 383.0 | 36 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 369.0 | 40 | ||||
N2586 | 3 | M-CSF | 297.0 | 55 |